Health Dictionary Find a Doctor

Turner syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Synonyms and keywords: Turner syndrome, 45 XO, short stature, sex chromosomal anomaly

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Historical Perspective

Turner syndrome was first described in 1938 by Henry Turner when he noticed a triad of short stature, cubitus valgus and pterygium colli. Other scientists went to to discover the pathophysiology of the 45 XO karyotype and the presence of streaked ovaries.

Classification

There is no established system for the classification of Turner syndrome.

Pathophysiology

Humans have 46 chromosomes. Chromosomes contain all of your genes and DNA, the building blocks of the body. Two of these chromosomes, the sex chromosomes, determine if you become a boy or a girl. Loss the paternally or maternally derived X chromosome would lead to the class 45 XO karyotype. Sometimes, an individual may have two cells lines with different genetic makeups. The percentage of this mosaicism is said to determine the severity of the phenotype in the patient. Structural abnormalities such as the formation of a ring chromosome or an isochromosome and other mechanisms such as lyonization or imprinting also play a role in the pathophysiology of Turner Syndrome.

Causes

Humans have 46 chromosomes. Chromosomes contain all of your genes and DNA, the building blocks of the body. Two of these chromosomes, the sex chromosomes, determine if you become a boy or a girl. Females normally have two of the same sex chromosomes, written as XX. Males have an X and a Y chromosome (written as XY). In Turner syndrome, cells are missing all or part of an X chromosome. The condition only occurs in females. Most commonly, the female patient has only one X chromosome. Others may have two X chromosomes, but one of them is incomplete. Sometimes, a female has some cells with two X chromosomes, but other cells have only one.

Differentiating Turner syndrome from Other Diseases

Turner’s syndrome must be differentiated from other diseases that cause latency in secondary sexual characteristics development, such as constitutional delay of puberty, hypopituitarism, delayed puberty, and chromosomal abnormalities. Chromosomal abnormality is Noonan’s syndrome.

Epidemiology and Demographics

The incidence rate of Turner is 1 of 2500 live births. Turner Syndrome patients have a higher mortality rate compared to the general population.

Risk Factors

There is currently no known cause for Turner syndrome, though there are several theories surrounding the subject.

Screening

Screening for complications of Turner syndrome starts as early as a prenatal visit. Abnormal maternal serum screening tests or an ultrasound detecting structural anomalies such shortned limbs, cystic hygromas, congenital heart defects or increased swelling of the hands or feet may point towards a diagnosis of Turner syndrome. As the years progress, screening involves a multidisciplinary combination of lab investigations (such as serum gonadotrophins,liver function tests, renal function tests, etc), referral to other departments (cardiology, endocrinology, ophthalmology, etc) and tools such as DEXA scans, X-rays, echocardiography, etc.

Natural History, Complications, and Prognosis

Natural history of the patient would depend on the age of the diagnoses and what complications have developed by the time the patients presents to the physician. Congenital lymphedema may take several years to decrease. The patient experiences low self esteem due to their short stature, decreased visual spatial functioning, hyperactivity, poor facial recognition and preference for social isolation. As soon as the patient is capable of understanding, counseling regarding the risks and benefits of Turner syndrome should be explained. When compared to the general population, Turner syndrome patients have an increased mortality rate.

Diagnosis

Diagnostic Study of Choice

The diagnostic study of choice for the diagnosis of Turner syndrome is karyotype analysis of 30 blood lymphocytes. Examination of additional cells , polymerase chain reaction, fluorescent in situ hybridization, Southern blotting, restricted fragment length polymorphisms and new generation gene sequencing techniques may be employed following the interpretation of the initial karyotype.

History and Symptoms

Natural history of the patient would depend on the age of the diagnoses and what complications have developed by the time the patients presents to the physician. Congenital lymphedema may take several years to decrease. The patient experiences low self esteem due to their short stature, decreased visual spatial functioning, hyperactivity, poor facial recognition and preference for social isolation. As soon as the patient is capable of understanding, counseling regaridng the risks and benefits of Turner syndrome should be explained.

Physical Examination

Physical examination may be suggestive of thyroid dysfunction, congenital heart defects, inflammatory bowel disease, characteristic skeletal deformities and body habitus/skin manifestations.

Laboratory Findings

Laboratory investigations serve as important screening tools for thyroid dysfunction, renal dysfunction, liver dysfunction, new onset diabetes mellitus,vitamin D deficiency and ovarian reserve.

Electrocardiogram

An electrocardiogram is not employed in the diagnosis of Turner syndrome.

X-ray

A x-ray may be used to diagnose cardiac and skeletal abnormalities.

Echocardiography and Ultrasound

Prenatal ultrasounds my show a left-sided cardiac defect, renal anomalies, growth retardation, relatively short limbs, fetal edema, cystic hygroma, polyhydramnios and brachycephaly. Echocardiographies and renal ultrasounds help detect structural defects.

CT scan

Simple CTs or CT angiographies are helpful in screening/detecting the following cardiac abnormalities.

MRI

Cardiac MRIs are helpful in screening/detecting the following cardiac abnormalities and functional MRIs have been used to study neural pathways responsible for poor visual spatial skills and executive function.

Other Imaging Findings

There are no other imaging findings associated with Turner syndrome.

Other Diagnostic Studies

The diagnostic study of choice for the diagnosis of Turner syndrome is karyotype analysis of 30 blood lymphocytes. Findings may include the classic 45 XO karyotype, mosaicism and structural anomalies like isochromosomes or ring chromosomes.

Treatment

Medical Therapy

Medical therapies include growth hormone, estrogen replacement therapy, oxandrolone (if growth hormone achieves suboptimal height), vitamin D supplementation, oral hypoglycemic agents and anti-hypertensives.

Interventions

Psycosocial interventions aimed at treating ][visual spatial and executive function]] deficits along with in vitro fertilization (for infertility) are the interventions commonly used in Turner syndrome.

Surgery

Surgery is indicated for craniofacial anomalies, to decrease the risk of aortic dissection and for congenital pterygium colli.

Primary Prevention

There are no established measures for the primary prevention of Turner syndrome.

Secondary Prevention

There are no established measures for the secondary prevention of Turner Syndrome. Secondary prevention is aimed at preventing complications of Turner syndrome. This involves frequent screening of complications.

References


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Turner syndrome was first described in 1938 by Henry Turner when he noticed a triad of short stature, cubitus valgus and pterygium colli. Other scientists went to to discover the pathophysiology of the45 XO karyotype and the presence of streaked ovaries.

Historical Perspective

References

  1. Lowenstein EJ, Kim KH, Glick SA (2004). “Turner’s syndrome in dermatology”. J Am Acad Dermatol. 50 (5): 767–76. doi:10.1016/j.jaad.2003.07.031. PMID 15097963.


Template:WikiDoc Sources

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

There is no established system for the classification of Turner syndrome.

Classification

There is no established system for the classification of Turner syndrome.

References

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Humans have 46 chromosomes. Chromosomes contain all of your genes and DNA, the building blocks of the body. Two of these chromosomes, the sex chromosomes, determine if you become a boy or a girl. Loss the paternally or maternally derived X chromosome would lead to the class 45 XO karyotype. Sometimes, an individual may have two cells lines with different genetic makeups. The percentage of this mosaicism is said to determine the severity of the phenotype in the patient. Structural abnormalities such as the formation of a ring chromosome or an isochromosome and other mechanisms such as lyonization or imprinting also play a role in the pathophysiology of Turner Syndrome.

Pathophysiology

Karyotypes

Nondisjunction

Chromosomal structure

Nonfunctional Y

Mosaicism

  • Each of the causes mentioned above can occur as a mosaicism, that is, some of the cells carry the mutation and some don’t. That is, two cell lines of different genetic make ups exist.
  • This happens if the error takes place in one cell after the very first divisions of the early embryo after fertilization.
  • The exact mixture of the two different cell types depends on when the nondisjunction occurred. *However, if the nondisjunction occurs after enough divisions, the fraction of abnormal cells is probably not large enough to show any significant effects.
  • For instance, such a 45,X/46,XY individual will develop as a male, without Turner syndrome.
    • It is hypothesized that lower the percentage of mosaicism, the lesser is the phenotype expression.
  • Mosaicism is found in about 20% of individuals with Turner syndrome.

No single Y

Lyonization

Imprinting

  • Imprinting is an alteration in the expression of a gene, depending on whether it has been inherited from the mother or father.
  • In the case of imprinting, it is not known whether there is a specific correlation between retention of the maternal or paternal chromosome and expression of particular phenotype.

References

  1. 1.0 1.1 Sybert VP, McCauley E (2004). “Turner’s syndrome”. N Engl J Med. 351 (12): 1227–38. doi:10.1056/NEJMra030360. PMID 15371580.
  2. Cui X, Cui Y, Shi L, Luan J, Zhou X, Han J (2018). “A basic understanding of Turner syndrome: Incidence, complications, diagnosis, and treatment”. Intractable Rare Dis Res. 7 (4): 223–228. doi:10.5582/irdr.2017.01056. PMC 6290843. PMID 30560013.
  3. 3.0 3.1 Kesler SR (2007). “Turner syndrome”. Child Adolesc Psychiatr Clin N Am. 16 (3): 709–22. doi:10.1016/j.chc.2007.02.004. PMC 2023872. PMID 17562588.
  4. Frías JL, Davenport ML, Committee on Genetics and Section on Endocrinology (2003). “Health supervision for children with Turner syndrome”. Pediatrics. 111 (3): 692–702. doi:10.1542/peds.111.3.692. PMID 12612263.
  5. Collett-Solberg PF, Gallicchio CT, Coelho SC, Siqueira RA, Alves ST, Guimarães MM (2011). “Endocrine diseases, perspectives and care in Turner syndrome”. Arq Bras Endocrinol Metabol. 55 (8): 550–8. doi:10.1590/s0004-27302011000800008. PMID 22218436.


Template:WikiDoc Sources

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Humans have 46 chromosomes. Chromosomes contain all of your genes and DNA, the building blocks of the body. Two of these chromosomes, the sex chromosomes, determine if you become a boy or a girl. Females normally have two of the same sex chromosomes, written as XX. Males have an X and a Y chromosome (written as XY).

In Turner syndrome, cells are missing all or part of an X chromosome. The condition only occurs in females. Most commonly, the female patient has only one X chromosome. Others may have two X chromosomes, but one of them is incomplete. Sometimes, a female has some cells with two X chromosomes, but other cells have only one.

Causes

Turner syndrome results from the following mechanisms.

Karyotypes

Nondisjunction

Chromosomal structure

  • An X chromosome can form a ring chromosome for example by losing a portion of the smaller arm, enabling the end of the long arm to wrap around. This is detrimental for the X chromosome in two ways. **Either the lost portion itself makes the chromosome less functional.
    • Or it causes nondisjunction, as described above. Thus, the causes listed here are partly overlapping.
  • When such a ring chromosome combines with another ring chromosome in fertilization, the pair is denoted as 46, XrXp-, where rXp- means a ring chromosome missing the small (p) arm of the chromosome.
  • Another variant of abnormal chromosomal structure is chromosomes with two long arms of the X chromosomes attached, and are called isochromosomes.
  • Variants of chromosomal structure occur in 30% of individuals with Turner syndrome.

Nonfunctional Y

  • Very rarely, the embryo has a normal X chromosome and a portion of the Y chromosome.
  • In these cases, the Y chromosome does not have a functional SRY (and so develops as a female), the diagnosis is XY gonadal dysgenesis.[1]
  • It is possible that some Turner syndrome diagnosis is due to gonadal dysgenesis, particularly when it is caused by a large deletion of the Y chromosome.

Mosaicism

  • Each of the causes mentioned above can occur as a mosaicism, that is, some of the cells carry the mutation and some don’t. That is, two cell lines of different genetic make ups exist.
  • This happens if the error takes place in one cell after the very first divisions of the early embryo after fertilization.
  • The exact mixture of the two different cell types depends on when the nondisjunction occurred. *However, if the nondisjunction occurs after enough divisions, the fraction of abnormal cells is probably not large enough to show any significant effects.
  • For instance, such a 45,X/46,XY individual will develop as a male, without Turner syndrome.
    • It is hypothesized that lower the percentage of mosaicism, the lesser is the phenotype expression.
  • Mosaicism is found in about 20% of individuals with Turner syndrome.

No single Y

  • There is no equivalent syndrome which results in a Y chromosome with no X, as such a condition is fatal in utero.

Lyonization

  • In a normal 46 XX female, a process called lyonization inactivates one of the X chromosomes to equalize the number of expressible genes in males and females.
  • Some genes escape this inactivation and contribute to the pathophysiology in Turner Syndrome.
  • Turner syndrome might be due to the partial or complete absence of these inactivated genes and the presence of functional homologues of the Y chromosome. [1]

Imprinting

  • Imprinting is an alteration in the expression of a gene, depending on whether it has been inherited from the mother or father.
  • In the case of imprinting, it is not known whether there is a specific correlation between retention of the maternal or paternal chromosome and expression of particular phenotype.

References

  1. Kesler SR (2007). “Turner syndrome”. Child Adolesc Psychiatr Clin N Am. 16 (3): 709–22. doi:10.1016/j.chc.2007.02.004. PMC 2023872. PMID 17562588.


Template:WikiDoc Sources

Differentiating Turner syndrome from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2] Akash Daswaney, M.B.B.S[3]

Overview

Turner’s syndrome must be differentiated from other diseases that cause latency in secondary sexual characteristics development, such as constitutional delay of puberty, hypopituitarism, delayed puberty, and chromosomal abnormalities. Chromosomal abnormality is Noonan’s syndrome.

Differentiating Turner’s syndrome from other diseases

Diseases Laboratory Findings Physical examinations Other Findings
GnRH LH FSH Estradiol Testosterone Lack of secondary sexual characteristics Amenorrhea Webbed neck Final height
Turner’s syndrome + + + Bicuspid aortic valve
Delayed puberty Primary hypogonadism + +
Secondary hypogonadism + +
Constitutional delay of puberty Nl Nl Nl Nl Nl + + Nl Normal puberty, finally
Hypopituitarism + +
Noonan’s syndrome + + Nl Mitral valve prolapse
Outflow tract obstruction

(imperforate hymen or transverse vaginal septum)

Nl Nl Nl Nl Nl + Nl Imperforate hymen

Perirectal mass

Bulging hymen with hematocolpos

Mayer-Rokitansky-Kuster-Hauser syndrome Nl Nl Nl Nl Nl + Nl Variable absence of Mullerian structures in pelvic ultrasound

Other differentials

Turner syndrome must be differentiated from other similar conditions which lead to multiple endocrine disorders such as autoimmune polyendocrine syndrome, POEMS syndrome, Hirata syndrome, Kearns–Sayre syndrome and Wolfram syndromes.[2][3][4][5][6]

Disease Addison’s disease Type 1 diabetes mellitus Hypothyroidism Other disorders present
APS type 1 + Less common Less common Hypoparathyroidism
Candidiasis
Hypogonadism
APS type 2 + + + Hypogonadism
Malabsorption
APS type 3 + + Malabsorption
Thymoma + + Myasthenia gravis
Cushing syndrome
Chromosomal abnormalities
(Turner syndrome,
Down’s syndrome)
+ + Cardiac dysfunction
Kearns–Sayre syndrome + Myopathy
Hypoparathyroidism
Hypogonadism
Wolfram syndrome + Diabetes insipidus
Optic atrophy
Deafness
POEMS syndrome + Polyneuropathy
Hypogonadism
Plasma cell dyscrasias

References

  1. Blondell RD, Foster MB, Dave KC (1999). “Disorders of puberty”. Am Fam Physician. 60 (1): 209–18, 223–4. PMID 10414639.
  2. Sherer Y, Bardayan Y, Shoenfeld Y (1997). “Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases (Review)”. Int. J. Oncol. 10 (5): 939–43. PMID 21533467.
  3. Nozza, Andrea (2017). “POEMS SYNDROME: AN UPDATE”. Mediterranean Journal of Hematology and Infectious Diseases. 9 (1): e2017051. doi:10.4084/mjhid.2017.051. ISSN 2035-3006.
  4. Maceluch JA, Niedziela M (2006). “The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy”. Pediatr Endocrinol Rev. 4 (2): 117–37. PMID 17342029.
  5. Rigoli L, Di Bella C (2012). “Wolfram syndrome 1 and Wolfram syndrome 2”. Curr. Opin. Pediatr. 24 (4): 512–7. doi:10.1097/MOP.0b013e328354ccdf. PMID 22790102.
  6. Husebye, Eystein S.; Anderson, Mark S. (2010). “Autoimmune Polyendocrine Syndromes: Clues to Type 1 Diabetes Pathogenesis”. Immunity. 32 (4): 479–487. doi:10.1016/j.immuni.2010.03.016. ISSN 1074-7613.


Template:WikiDoc Sources

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

The incidence rate of Turner syndrome is 1 of 2500 live births. Turner Syndrome patients have a higher mortality rate compared to the general population.

Epidemiology

References

  1. Cui X, Cui Y, Shi L, Luan J, Zhou X, Han J (2018). “A basic understanding of Turner syndrome: Incidence, complications, diagnosis, and treatment”. Intractable Rare Dis Res. 7 (4): 223–228. doi:10.5582/irdr.2017.01056. PMC 6290843. PMID 30560013.
  2. Gravholt CH (2005). “Clinical practice in Turner syndrome”. Nat Clin Pract Endocrinol Metab. 1 (1): 41–52. doi:10.1038/ncpendmet0024. PMID 16929365.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

There is currently no known cause for Turner syndrome, though there are several theories surrounding the subject.

Risk Factors

  • There is currently no known cause for Turner syndrome, though there are several theories surrounding the subject.

References


Template:WikiDoc Sources

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Screening for complications of Turner syndrome starts as early as a prenatal visit. Abnormal maternal serum screening tests or an ultrasound detecting structural anomalies such shortened limbs, cystic hygromas, congenital heart defects or increased swelling of the hands or feet may point towards a diagnosis of Turner syndrome. As the years progress, screening involves a multidisciplinary combination of lab investigations (such as serum gonadotrophins, liver function tests, renal function tests, etc), referral to other departments (cardiology, endocrinology, ophthalmology, etc) and tools such as DEXA scans, X-rays, echocardiography, etc.

Screening


2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[4]

Diagnostic and Therapeutic Recommendations for Turner Syndrome

Class I
1.Women with Turner syndrome should be evaluated for bicuspid aortic valve, coarctation of the aorta, and enlargement of the ascending aorta. (Level of Evidence: B-NR)
Class IIa
1.Prophylactic replacement of the aortic root or ascending aorta in adults with Turner syndrome is reasonable when the aortic diameter is 2.5 cm/m2 or greater.

(Level of Evidence: B-NR)

References

  1. Shankar RK, Backeljauw PF (2018). “Current best practice in the management of [[Turner syndrome]]”. Ther Adv Endocrinol Metab. 9 (1): 33–40. doi:10.1177/2042018817746291. PMC 5761955. PMID 29344338. URL–wikilink conflict (help)
  2. Frías JL, Davenport ML, Committee on genetics and Section on endocrinology (2003). “Health supervision for children with Turner syndrome”. Pediatrics. 111 (3): 692–702. doi:10.1542/peds.111.3.692. PMID 12612263.
  3. Wolff DJ, Van Dyke DL, Powell CM, Working Group of the ACMG Laboratory Quality Assurance Committee (2010). “Laboratory guideline for Turner syndrome”. Genet Med. 12 (1): 52–5. doi:10.1097/GIM.0b013e3181c684b2. PMID 20081420.
  4. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]

Overview

Natural history of the patient would depend on the age of the diagnoses and what complications have developed by the time the patients presents to the physician. Congenital lymphedema may take several years to decrease. The patient experiences low self esteem due to their short stature, decreased visual spatial functioning, hyperactivity, poor facial recognition and preference for social isolation. As soon as the patient is capable of understanding, counseling regarding the risks and benefits of Turner syndrome should be explained. When compared to the general population, Turner syndrome patients have an increased mortality rate.

Natural History and Complications[1][2]

System Clinical features and Complications
Gonadal
Endocrine
Gastrointestinal and hepatic
Ophthalmology
Otorhinolayngology
Neck
Chest
  • Wide shield shaped chest with broadly spaced inverted nipples
Skin, hair and nail
Skeletal
Cardiac
Renal
Psychological

Special Notes [3]

Prognosis

References

  1. Adhikary HP (1981). “Ocular manifestations of Turner’s syndrome”. Trans Ophthalmol Soc U K. 101 (Pt 4): 395–6. PMID 6964261.
  2. Gravholt CH (2005). “Clinical practice in Turner syndrome”. Nat Clin Pract Endocrinol Metab. 1 (1): 41–52. doi:10.1038/ncpendmet0024. PMID 16929365.
  3. 3.0 3.1 Kesler SR (2007). “Turner syndrome”. Child Adolesc Psychiatr Clin N Am. 16 (3): 709–22. doi:10.1016/j.chc.2007.02.004. PMC 2023872. PMID 17562588.
  4. Frías JL, Davenport ML, Committee on Genetics and Section on Endocrinology (2003). “Health supervision for children with Turner syndrome”. Pediatrics. 111 (3): 692–702. doi:10.1542/peds.111.3.692. PMID 12612263.
  5. Sybert VP, McCauley E (2004). “Turner’s syndrome”. N Engl J Med. 351 (12): 1227–38. doi:10.1056/NEJMra030360. PMID 15371580.
  6. Wolff DJ, Van Dyke DL, Powell CM, Working Group of the ACMG Laboratory Quality Assurance Committee (2010). “Laboratory guideline for Turner syndrome”. Genet Med. 12 (1): 52–5. doi:10.1097/GIM.0b013e3181c684b2. PMID 20081420.


Template:WikiDoc Sources

Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters


cs:Turnerův syndrom de:Turner-Syndrom ko:터너 증후군 it:Sindrome di Turner he:תסמונת טרנר lt:Ternerio sindromas nl:Syndroom van Turner no:Turner syndrom nn:Turners syndrom sr:Тарнеров синдром fi:Turnerin syndrooma sv:Turners syndrom


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH